Do Biopharma Companies Really Spend More on Marketing Than R&D?

As the drug pricing debate on Capitol Hill continues, the debate over how biopharma companies spend also continues.

From 2014 through 2016, various publications—from the Washington Post to Vox to MedCity News—published an eye-opening chart showing that nine of the top 10 large pharmaceutical companies (all but Roche) spent more on marketing than research and development (R&D).